Post job

Amneal Pharmaceuticals's revenue is $2.8 billion.

What is Amneal Pharmaceuticals's revenue?

Amneal Pharmaceuticals's annual revenue is $2.8B. Zippia's data science team found the following key financial metrics about Amneal Pharmaceuticals after extensive research and analysis.
  • Amneal Pharmaceuticals's revenue growth from 2018 to 2024 is 68.01%.
  • Amneal Pharmaceuticals has 6,500 employees, and the revenue per employee ratio is $429,839.
  • Amneal Pharmaceuticals's peak quarterly revenue was $730.5M in 2024(q4).
  • Amneal Pharmaceuticals annual revenue for 2023 was 2.4B, 8.2% growth from 2022.
  • Amneal Pharmaceuticals annual revenue for 2024 was 2.8B, 16.73% growth from 2023.
  • Amneal Pharmaceuticals peak revenue was $2.8B in 2024.

On this page

Most recent quarter revenue
$730.5M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$2.8B (2024)
Company peak revenue
Revenue / employee
$429,840
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Most recent quarter revenue
$730.5M (Q4'2024)
Company most recent quarter revenue
Peak revenue
$2.8B (2024)
Company peak revenue
Revenue / employee
$429,840
Company revenue / employee

Amneal Pharmaceuticals historical revenue

Amneal Pharmaceuticals's peak revenue was $2.8B in 2024. The peak quarterly revenue was $730.5M in 2024(q4).

Amneal Pharmaceuticals's revenue increased from $1.7b in 2018 to $2.8B currently. That's a 68.01% change in annual revenue.

Amneal Pharmaceuticals annual revenue

$3B
$2B
$2B
$1B
$559M
$0
2019
2020
2021
2022
2023
2024

Amneal Pharmaceuticals annual revenue over time

Fiscal year / yearAmneal Pharmaceuticals revenue
2018$1.7B
2019$1.6B
2020$2.0B
2021$2.1B
2022$2.2B
2023$2.4B
2024$2.8B

How accurately did Amneal Pharmaceuticals' revenue projections match actual performance?

Zippia waving zebra

Amneal Pharmaceuticals annual growth

Amneal Pharmaceuticals saw the greatest revenue growth in 2020, when revenue increased by 22.51%.

Amneal Pharmaceuticals had the lowest revenue growth in 2019, when revenue changed by -2.2%.

Amneal Pharmaceuticals annual growth rate over time

YearAmneal Pharmaceuticals growth
2019
-2%
2020
23%
2021
5%
2022
6%
2023
8%
2024
17%

Amneal Pharmaceuticals quarterly revenue over time

  • Q1
  • Q2
  • Q3
  • Q4
$731M
$584M
$438M
$292M
$146M
$0
2020
2021
2022
2023
2024

Amneal Pharmaceuticals quarterly growth rate over time

YearQ1Q2Q3Q4
2018-$413.8M$476.5M$497.5M
2019$446.1M$404.6M$378.3M$397.3M
2020$498.5M$464.7M$519.3M$510.0M
2021$493.1M$535.1M$528.6M$536.9M
2022$497.6M$559.4M$545.6M$609.8M
2023$557.5M$599.0M$620.0M$617.0M
2024$659.2M$701.8M$702.5M$730.5M

Amneal Pharmaceuticals jobs nearby

Do you work at Amneal Pharmaceuticals?

Did Amneal Pharmaceuticals meet its revenue projections?

Amneal Pharmaceuticals financial information

CEOChirag K. Patel
IndustryPharmaceuticals, Biotechnology & Life Sciences
Company TypePublic
Employees Number6,500
Date Founded2002
HeadquartersBridgewater, New Jersey
Number of Locations7
Revenue$2.8B
Net Income-$250,044,000
Gross Proft$1.0B (2024)
Tax Rate-0.3%
Total Assets$3,799,341,000
TickerAMRX

Amneal Pharmaceuticals jobs you might like

Amneal Pharmaceuticals financing

Amneal Pharmaceuticals received early financing of $854.0M on 2017-10-01.

SeriesRound sizeDate
Post Ipo Equity$854M10/2017

Amneal Pharmaceuticals investors

InvestorsSecurity type
TPGPost Ipo Equity
FMR Co.Post Ipo Equity

Amneal Pharmaceuticals competitors

Amneal Pharmaceuticals's top competitor, Johnson & Johnson, earned an annual revenue of $88.8B.

Amneal Pharmaceuticals's smallest competitor is Frontage Laboratories with revenue of $560.0K last year.

Amneal Pharmaceuticals revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Amneal Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Amneal Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Amneal Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Amneal Pharmaceuticals. The data presented on this page does not represent the view of Amneal Pharmaceuticals and its employees or that of Zippia.

Amneal Pharmaceuticals may also be known as or be related to Amneal Pharmaceuticals, Amneal Pharmaceuticals LLC and Amneal Pharmaceuticals, Inc.